Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Sep 10, 2026
Tradr 2X Long BE Daily ETF (BEX) +51% Rally: Bloom Energy (BE) AI Power Momentum at Work

Tradr 2X Long BE Daily ETF (BEX) +51% Rally: Bloom Energy (BE) AI Power Momentum at Work

Key Takeaways

  • The Tradr 2X Long BE Daily ETF gained roughly 51% over the trailing 30 days, rebounding from a July trough near $15 to about $22.62.
  • The move mirrors a strong recovery in its sole underlying exposure, Bloom Energy Corp. (BE), which advanced about 29% over the same stretch.
  • Primary catalysts include Bloom Energy's record second-quarter results, raised 2026 guidance, and new AI data center power agreements.
  • Despite the recent rally, BEX remains down roughly 65% over the trailing three months, highlighting the extreme volatility of a 2x daily leveraged single-stock fund.
  • Because BEX resets its leverage daily, returns over periods longer than one day can diverge materially from twice the cumulative return of BE.

BEX ETF Overview and Its Exposure to Bloom Energy (BE)

BEX is a leveraged, single-stock exchange-traded fund (ETF) that seeks daily investment results, before fees and expenses, equal to 200% of the daily performance of Bloom Energy Corp. (BE) common stock. Launched in November 2025, the fund is non-diversified and is structured as a short-term trading vehicle rather than a buy-and-hold core holding.

Unlike a traditional basket ETF, BEX holds a small number of positions—typically fewer than five—consisting primarily of total return swaps and other derivative instruments designed to deliver leveraged exposure to Bloom Energy, alongside cash and cash equivalents. The fund carries a net expense ratio of 1.30%, and its assets under management (AUM) have grown to roughly $180 million as the underlying stock's volatility has attracted trading interest.

Because virtually all of BEX's risk is concentrated in one stock, fund performance is an amplified reflection of Bloom Energy's price action. When the underlying moves sharply in either direction, BEX tends to move roughly twice as far on any given day, making single-name fundamentals and sector exposure the dominant drivers of returns. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Recent Price Performance of BEX: 30 Days vs. Three Months

Over the trailing 30 days, BEX climbed from approximately $15.00 to $22.62, a gain of about 51%. The advance was not a smooth trend; it followed a sharp July drawdown and featured repeated double-digit daily swings characteristic of leveraged products.

The longer-term picture is more sobering. Over the trailing three months, BEX declined roughly 65%, falling from about $64.43 to $22.62. This divergence—a strong one-month rally inside a deep three-month drawdown—illustrates both the fund's volatility and the compounding effects of daily leverage resets.

Factors Behind the 30-Day Rebound in BEX

The 30-day rebound was driven almost entirely by the recovery in Bloom Energy. The company reported second-quarter revenue of $1.07 billion, up 165.5% year over year, with adjusted earnings per share (EPS) of $0.78—roughly double consensus estimates—and raised its full-year 2026 revenue outlook to between $3.9 billion and $4.2 billion.

Momentum also came from the AI data center power theme. Commentary from Nvidia Corp. (NVDA) about multi-year timelines for securing grid power reinforced demand for Bloom's on-site solid-oxide fuel cells, which can be deployed far faster than traditional grid connections. New and expanded agreements—including a 300-megawatt deal with Nebius Group (NBIS) and an expanded Oracle Corp. (ORCL) framework of up to 2.8 gigawatts—supported the investment thesis.

Analyst actions added further fuel, with several firms raising price targets or upgrading ratings following the earnings beat. The rally also reflected a partial recovery from July's short-seller-driven selloff tied to questions about Bloom's scandium supply chain, claims the company has disputed.

The Quarter’s Volatility and BEX’s Drawdown

The trailing quarter has been a story of whipsaw. After reaching a high near $86 in late June, BEX collapsed through July as a pair of short-seller reports questioned Bloom Energy's reliance on Chinese-sourced scandium and as broader AI-related volatility triggered profit-taking in a stock that had already surged several hundred percent over the prior year. Bloom shares fell more than 30% in July, and the 2x leverage magnified the drawdown in BEX.

Valuation concerns compounded the selling: with Bloom trading near a $70 billion market capitalization and a premium earnings multiple, even a strong earnings report initially produced a "sell the news" reaction. The subsequent August recovery reflected renewed institutional conviction around data center power demand, stabilizing sentiment, and Bloom's expanding backlog, which stood near $20 billion at the start of 2026 with product orders up about 140% year over year.

BEX ETF Outlook and Key Risks to Watch

BEX's path will continue to be dictated by Bloom Energy and the broader AI power buildout. Key factors to monitor include Bloom's ability to convert its growing backlog into shipped product and recurring service revenue, the pace of hyperscaler and neocloud power procurement, and any new contract announcements.

Risks remain substantial. Supply-chain questions around scandium, competition from natural-gas turbines and nuclear generation, regulatory and permitting hurdles at large projects, and Bloom's premium valuation could all reignite volatility. Macroeconomic forces—interest rate expectations and inflation trends that influence the cost of capital for AI infrastructure—will also shape investor sentiment.

Most importantly, investors should understand that BEX is engineered for short-term trading. The daily reset of leverage means the fund can lose value even in a flat or recovering underlying market over time, and its 1.30% expense ratio, combined with volatility drag, makes it unsuitable as a long-term holding for most investors. From what I see, this remains an important consideration for anyone evaluating the position.

Monitoring with Tickeron’s AI Screener

I also checked this using Tickeron’s AI Screener, an AI-powered discovery platform that scans thousands of securities using technical indicators, fundamentals, volatility metrics, price patterns, industry filters, and AI-generated signals. The tool is designed to help investors identify trending securities, breakout candidates, and shifting market conditions more efficiently than manual screening. For traders tracking fast-moving, high-volatility instruments such as leveraged ETFs, screening by momentum and volatility characteristics can provide useful context alongside fundamental research.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BEX

Contributor

My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.


BEX in upward trend: price rose above 50-day moving average on September 04, 2026

BEX moved above its 50-day moving average on September 04, 2026 date and that indicates a change from a downward trend to an upward trend. In of 7 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 01, 2026. You may want to consider a long position or call options on BEX as a result. In of 11 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a +3 3-day Advance, the price is estimated to grow further. Considering data from situations where BEX advanced for three days, in of 43 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BEX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BEX broke above its upper Bollinger Band on September 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for BEX entered a downward trend on August 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Industry description

The investment seeks daily investment results, before fees and expenses, that correspond to two times (200%) the daily performance of the common shares of Bloom Energy Corporation. Under normal market circumstances, the fund will maintain at least 80% exposure to financial instruments that provide two times leveraged exposure to the daily performance of BE. This may include BE stock in addition to financial instruments. The fund is non-diversified.
View a ticker or compare two or three
BEX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Trading

Profile
Details
Category
Trading--Leveraged Equity
Address
Investment Managers Series Trust II803 West Michigan StreetMilwaukee
Phone
(414) 299-2295
Web
N/A
Interact to see
Advertisement
Shares of CRDO surged +11.90% on March 5, 2026, closing at $114.74 versus a prior close of $102.54. Primary catalyst: Strong Q3 fiscal 2026 earnings reported on March 2, with revenue of $407 million beating consensus estimates by more than $19 million and non-GAAP EPS of $1.07 surpassing forecasts by $0.29.
SPY is trading down approximately -1.30% in Friday premarket, slipping from the prior session's close of $681.31 to around $677–$678. The primary catalyst is a sharply negative February 2026 Nonfarm Payrolls report, which showed a decline of 92,000 jobs — a massive miss versus the consensus forecast of +50,000.
WAL shares dropped approximately 12% in early trading on March 6, 2026, from a prior close of ~$80.74 to roughly ~$71, marking one of the stock's sharpest single-session declines in recent months. The primary catalyst was a surprise announcement that Jefferies Financial Group declined to make a $126.4 million payment owed to Western Alliance Bank under a forbearance agreement tied to the LAM Trade Finance loan portfolio.
MRVL shares surged approximately +15% at the open on March 6, 2026, after closing at $75.68 the prior session. The primary catalyst was a strong Q4 fiscal 2026 earnings report released after the close on March 5, with non-GAAP EPS of $0.80 beating the $0.79 consensus estimate and revenue of $2.219 billion exceeding expectations.
Shares of Day One Biopharmaceuticals surged approximately +65.57% on March 6, 2026, rising from a prior close of $12.78 to an intraday price around $21.16. The primary catalyst driving the session's gains is acquisition and takeover speculation, with reports circulating that Day One may be a buyout target.
GAP shares fell approximately 13% in early trading on March 6, 2026, following the company's Q4 fiscal 2025 earnings report released after market close on March 5. Gap met Wall Street's Q4 estimates on both earnings per share and revenue, but fiscal 2026 guidance fell short of analyst expectations.
Shares of Red Cat Holdings surged approximately +22% in early Friday trading on March 6, 2026, building on a powerful week of momentum in defense drone stocks. The primary catalyst is escalating geopolitical conflict — U.S. and Israeli military strikes on Iran, which dramatically boosted investor appetite for domestic drone and defense technology companies.
The primary catalyst for the decline was the pricing of a secondary offering of roughly 9 million shares at about 22.25 dollars per share by Ingram Holdco, an affiliate of Platinum Equity, with all proceeds going to the selling shareholder and not to Ingram Micro itself. Investors often view such secondary offerings as short‑term bearish because they increase the freely tradable float and signal that a major holder is cashing out part of its stake, even if the company’s operations remain intact.
Rumble reported Q4 2025 revenue of about 27.1 million dollars, below consensus expectations near 29 million dollars and down roughly 10% year over year, confirming that top‑line momentum has stalled. GAAP EPS came in at a loss of around 0.13 dollars, missing analyst estimates by roughly 0.05 dollars and underscoring that the platform remains far from break‑even despite prior cost cuts and efficiency efforts.
Tronox’s Q4 2025 non‑GAAP EPS came in at a loss of about 0.60 dollars, missing expectations by roughly 0.02 dollars, while revenue of around 730 million dollars grew about 8% year over year, showing volume resilience but weak earnings power.
Defense budgets worldwide are surging — global military spending topped $2.2 trillion in 2023, a record high — while semiconductor demand is projected to reach a $1 trillion industry by 2030. At the intersection of these two mega-trends sits one of Tickeron's most strategically focused AI Trading Robots: the XAR, ITA, SOXL – AI Trading Agent (3 Tickers), 15min.
HIMS shares surged approximately +43.85% in premarket trading on Monday, March 9, 2026, rising from a prior close of $15.74 to around $22.80. Primary catalyst: Novo Nordisk officially ended its patent infringement lawsuit against Hims & Hers and announced a landmark partnership to distribute branded Wegovy through the Hims platform at $599/month.
XENE shares surged approximately +45.93% in premarket trading on March 9, 2026, one of the largest single-session moves in the company's history. The primary catalyst: Xenon announced positive topline Phase 3 X-TOLE2 results for its lead drug candidate azetukalner in focal onset seizures (FOS), meeting the primary endpoint with overwhelming statistical significance.
Shares of OLMA dropped approximately 41% in Monday's session, one of the steepest single-day declines in the company's history. The primary catalyst was Roche's Phase 3 persevERA trial failure — a late-stage study of giredestrant, a closely competing selective estrogen receptor degrader (SERD), which missed its primary endpoint of statistically significant improvement in progression-free survival.
RLMD shares surged approximately +40% at the open on March 9, 2026, rising from a prior close of $4.45 to approximately $6.23, driven by a major clinical trial readout. The primary catalyst was the announcement of 12-month interim data from the Phase 2 trial of NDV-01, Relmada's lead oncology candidate, in patients with high-risk non-muscle invasive bladder cancer (NMIBC) — results that significantly exceeded historical benchmarks.
CRCL surged +8.66% on Monday, March 9, 2026, rising from a prior close of $101.94 to trade at $110.77 intraday. The primary catalyst is a landmark stablecoin milestone: Circle's USDC overtook Tether as the dominant stablecoin by transfer volume, accounting for approximately 70% of all stablecoin transfer activity as total stablecoin transfers hit $1.8 trillion in February.
Carnival Corporation (CCL) shares fell approximately -7.60% in Monday's session, dropping from a Friday close of $25.79 to around $23.83. The primary catalyst is a broad market sell-off driven by intensifying recession fears, with the S&P 500 and consumer discretionary names bearing the brunt of the pressure.
Shares of Bloom Energy (BE) are surging approximately +10.30% in Monday's session, rebounding sharply from a steep -15.50% selloff on Friday, March 6, 2026. Friday's decline was triggered by an Oracle-OpenAI data center project update that spooked energy infrastructure investors; Monday's move reflects aggressive dip-buying and a sentiment reset.
IGV has rallied about 8–9% in the last 6 trading days, while SOXX has dropped about 8%, giving software a +16.6 percentage‑point edge—the largest 6‑day software‑over‑semi outperformance ever.[barchart]​ This comes right after software lagged semis by almost −15 percentage points into late January, the widest gap since 2008, and as hedge‑fund short exposure to U.S. software and services hit a record ~3.8% of market cap.
Crude’s explosive war‑driven spike faded on March 9 because the market suddenly started to price less extreme, shorter‑lived supply risk and more policy intervention, not a multi‑month shortage. WTI, which had briefly traded above 115–120 dollars on Iran‑war headlines and Strait of Hormuz fears, slid back toward the high‑80s as traders digested G7 reserve‑release talk, Trump’s comments about a “brief” war, and the reality that prices had run far ahead of fundamentals.